Pages that link to "Q34510611"
Jump to navigation
Jump to search
The following pages link to Maribavir pharmacokinetics and the effects of multiple-dose maribavir on cytochrome P450 (CYP) 1A2, CYP 2C9, CYP 2C19, CYP 2D6, CYP 3A, N-acetyltransferase-2, and xanthine oxidase activities in healthy adults (Q34510611):
Displaying 16 items.
- Pharmacokinetic Drug Interaction Studies with Enzalutamide (Q36087515) (← links)
- Conserved herpesvirus protein kinases (Q36491044) (← links)
- Effect of ketoconazole on the pharmacokinetics of maribavir in healthy adults (Q36593846) (← links)
- Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes (Q36863113) (← links)
- Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach (Q36720920) (← links)
- Therapeutic protein-drug interaction assessment for daclizumab high-yield process in patients with multiple sclerosis using a cocktail approach. (Q37030744) (← links)
- Maribavir: a novel antiviral agent with activity against cytomegalovirus (Q37242251) (← links)
- Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir. (Q37478310) (← links)
- The search for new therapies for human cytomegalovirus infections. (Q37811458) (← links)
- Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations. (Q38822159) (← links)
- Phenotyping of N-acetyltransferase type 2 and xanthine oxidase with caffeine: when should urine samples be collected? (Q46198088) (← links)
- Effect of tildrakizumab (MK-3222), a high affinity, selective anti-IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis (Q89174152) (← links)
- Advances in the Development of Therapeutics for Cytomegalovirus Infections (Q90062923) (← links)
- Enhanced Characterization of Drug Metabolism and the Influence of the Intestinal Microbiome: A Pharmacokinetic, Microbiome, and Untargeted Metabolomics Study (Q90678648) (← links)
- Effects of Upadacitinib Coadministration on the Pharmacokinetics of Sensitive Cytochrome P450 Probe Substrates: A Study With the Modified Cooperstown 5 1 Cocktail (Q92398648) (← links)
- Effects of Maribavir on P-Glycoprotein and CYP2D6 in Healthy Volunteers (Q92443666) (← links)